Mycophenolate mofetil Completed Phase 2 Trials for Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Secondary Myelodysplastic Syndromes / Recurrent Mantle Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Childhood Acute Lymphoblastic Leukemia in Remission / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Secondary Myelofibrosis / Recurrent Childhood Large Cell Lymphoma / Adult Erythroleukemia (M6a) / Recurrent Grade 2 Follicular Lymphoma / Adult Acute Minimally Differentiated Myeloid Leukemia (M0) / T-Cell Large Granular Lymphocyte Leukemia / Recurrent Adult Diffuse Mixed Cell Lymphoma / Childhood Nasal Type Extranodal NK/T-cell Lymphoma / Childhood Acute Myeloid Leukemia in Remission / Burkitt's Lymphoma / Relapsing Chronic Myelogenous Leukemia / Recurrent Marginal Zone Lymphoma / Stage III Chronic Lymphocytic Leukemia / Stage II Chronic Lymphocytic Leukemia / De Novo Myelodysplastic Syndromes / Recurrent Adult Burkitt Lymphoma / Previously Treated Myelodysplastic Syndromes / T-cell Adult Acute Lymphoblastic Leukemia / Recurrent Grade 3 Follicular Lymphoma / Childhood Acute Megakaryocytic Leukemia (M7) / Childhood Acute Erythroleukemia (M6) / Adult Acute Megakaryoblastic Leukemia (M7) / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / B-cell Adult Acute Lymphoblastic Leukemia / Adult Acute Monocytic Leukemia (M5b) / Chronic Myelomonocytic Leukemia / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Chronic Phase Chronic Myelogenous Leukemia / Nodal marginal zone B-cell lymphomas / Childhood Diffuse Large Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Recurrent Childhood Anaplastic Large Cell Lymphoma / Leukemia, Prolymphocytic / Recurrent Adult Acute Myeloid Leukemia / Childhood Acute Monocytic Leukemia (M5b) / Childhood Chronic Myelogenous Leukemia / Adult Acute Monoblastic Leukemia (M5a) / Recurrent Adult Immunoblastic Large Cell Lymphoma / Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) / Adult Acute Myeloid Leukemia in Remission / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / B-cell Childhood Acute Lymphoblastic Leukemia / Splenic Marginal Zone Lymphoma / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Adult Pure Erythroid Leukemia (M6b) / Stage I Chronic Lymphocytic Leukemia / Waldenström's Macroglobulinemia (WM) / Chronic Lymphocytic Leukemia (CLL) - Refractory / Recurrent Adult Acute Lymphoblastic Leukemia / Cutaneous B-Cell Non-Hodgkin Lymphoma / Stage IV Chronic Lymphocytic Leukemia / T-cell Childhood Acute Lymphoblastic Leukemia / Recurrent Childhood Small Noncleaved Cell Lymphoma / Childhood Acute Monoblastic Leukemia (M5a) / Recurrent Small Lymphocytic Lymphoma / Recurrent Childhood Acute Lymphoblastic Leukemia / Juvenile Myelomonocytic Leukemia / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Childhood Grade III Lymphomatoid Granulomatosis / Recurrent Childhood Acute Myeloid Leukemia / Recurrent Childhood Lymphoblastic Lymphoma / Adult Acute Lymphoblastic Leukemia in Remission / Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome / Recurrent Mycosis Fungoides/Sezary Syndrome / Blastic Phase Chronic Myelogenous Leukemia / Childhood Immunoblastic Large Cell Lymphoma / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Childhood Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01093586Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT00031655Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission
NCT01824693Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia